National Cancer Institute; Notice of Closed Meetings, 4610 [08-276]
Download as PDF
<![CDATA[
jlentini on PROD1PC65 with NOTICES
4610
Federal Register / Vol. 73, No. 17 / Friday, January 25, 2008 / Notices
Contact Person: Syed M. Quadri, PhD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6210,
MSC 7804, Bethesda, MD 20892, 301–435–
1211, quadris@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; VMD
Member Conflict Application Review.
Date: February 25, 2008.
Time: 4:30 p.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Los Angeles Airport Marriott, 5855
West Century Boulevard, Los Angeles, CA
90045.
Contact Person: Jin Huang, PhD, Scientific
Review Administrator, Center for Scientific
Review, National Institutes of Health, 6701
Rockledge Drive, Room 4095G, MSC 7812,
Bethesda, MD 20892, 301–435–1230,
jh377p@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflicts: DIG IRG: Transport, Metabolism,
Motility.
Date: February 25, 2008.
Time: 12 p.m. to 2:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Patricia Greenwel, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2174,
MSC 7818, Bethesda, MD 20892, 301–435–
1169, greenwep@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Research on
Primary Immunodeficiency Diseases.
Date: February 26, 2008.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Marriott Los Angeles Airport, 5855
West Century Boulevard, Los Angeles, CA
90045.
Contact Person: Jin Huang, PhD, Scientific
Review Administrator, Center for Scientific
Review, National Institutes of Health, 6701
Rockledge Drive, Room 4095G, MSC 7812,
Bethesda, MD 20892, 301–435–1230,
jh377p@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Cellmediated Immunity Member Conflict.
Date: February 27, 2008.
Time: 11 a.m. to 2 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Patrick K. Lai, PhD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2215,
MSC 7812, Bethesda, MD 20892, 301–435–
1052, laip@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; TTT
Overflow.
Date: February 28, 2008.
VerDate Aug<31>2005
16:59 Jan 24, 2008
Jkt 214001
Time: 8:30 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: The George Washington University
Inn, 824 New Hampshire Avenue, NW.,
Washington, DC 20037.
Contact Person: Calbert A. Laing, PhD,
Scientific Review Officer Center for Scientific
Review, National Institutes of Health, 6701
Rockledge Drive, Room 4210, MSC 7812,
Bethesda, MD 20892, 301–435–1221,
laingc@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: January 16, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 08–282 Filed 1–24–08; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications
and/or contract proposals and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
applications and/or contract proposals,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Institute Special Emphasis Panel; AVON–NCI
Progress for Patients Supplements.
Date: February 19, 2008.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6116
Executive Boulevard, Rockville, MD 20852.
Contact Person: Wlodek Lopaczynski, MD,
PhD, Scientific Review Administrator,
Research Programs Review Branch, Division
of Extramural Activities, National Cancer
Institute, 6116 Executive Blvd., Room 8131,
Bethesda, MD 20892, 301–594–1402,
lopacw@mail.nih.gov.
PO 00000
Frm 00095
Fmt 4703
Sfmt 4703
Name of Committee: National Cancer
Institute Special Emphasis Panel; Biology of
Breast Pre-Malignancies.
Date: February 27–28, 2008.
Time: 6 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: St. Gregory Hotel, 2033 M Street,
NW., Washington, DC 20036.
Contact Person: Irina V. Gordienko, PhD,
Scientific Review Administrator, Special
Review and Logistics Branch, Division of
Extramural Activities, National Cancer
Institute, 6116 Executive Boulevard, Room
7073, Bethesda, MD 20892–8329, 301–594–
1566, gordienkoiv@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel;
Multifunctional Therapeutics Based on
Nanotechnology.
Date: March 25–26, 2008.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate contract
proposals.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Jeffrey E. DeClue, PhD,
Scientific Review Administrator, Special
Review and Logistics Branch, Division of
Extramural Activities, National Cancer
Institute, 6116 Executive Boulevard, Room
8059, Bethesda, MD 20892–8329, 301–496–
7904, decluej@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: January 16, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 08–276 Filed 1–24–08; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Center for Complementary
and Alternative Medicine
Announcement of Grantsmanship
Workshop
ACTION:
Notice.
SUMMARY: The National Center for
Complementary and Alternative
Medicine (NCCAM) invites the research
community to apply to attend a
grantsmanship workshop. This
workshop will provide researchers,
fellows, and graduate students with an
in-depth understanding of the NIH
grants and review processes, clarify
E:\FR\FM\25JAN1.SGM
25JAN1
]]>Agencies
[Federal Register Volume 73, Number 17 (Friday, January 25, 2008)]
[Notices]
[Page 4610]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 08-276]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and/or contract proposals
and the discussions could disclose confidential trade secrets or
commercial property such as patentable material, and personal
information concerning individuals associated with the grant
applications and/or contract proposals, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Cancer Institute Special Emphasis
Panel; AVON-NCI Progress for Patients Supplements.
Date: February 19, 2008.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6116 Executive Boulevard,
Rockville, MD 20852.
Contact Person: Wlodek Lopaczynski, MD, PhD, Scientific Review
Administrator, Research Programs Review Branch, Division of
Extramural Activities, National Cancer Institute, 6116 Executive
Blvd., Room 8131, Bethesda, MD 20892, 301-594-1402,
lopacw@mail.nih.gov.
Name of Committee: National Cancer Institute Special Emphasis
Panel; Biology of Breast Pre-Malignancies.
Date: February 27-28, 2008.
Time: 6 p.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: St. Gregory Hotel, 2033 M Street, NW., Washington, DC
20036.
Contact Person: Irina V. Gordienko, PhD, Scientific Review
Administrator, Special Review and Logistics Branch, Division of
Extramural Activities, National Cancer Institute, 6116 Executive
Boulevard, Room 7073, Bethesda, MD 20892-8329, 301-594-1566,
gordienkoiv@mail.nih.gov.
Name of Committee: National Cancer Institute Special Emphasis
Panel; Multifunctional Therapeutics Based on Nanotechnology.
Date: March 25-26, 2008.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate contract proposals.
Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Jeffrey E. DeClue, PhD, Scientific Review
Administrator, Special Review and Logistics Branch, Division of
Extramural Activities, National Cancer Institute, 6116 Executive
Boulevard, Room 8059, Bethesda, MD 20892-8329, 301-496-7904,
decluej@mail.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS)
Dated: January 16, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 08-276 Filed 1-24-08; 8:45 am]
BILLING CODE 4140-01-M
